Dr Haider Raza Joins Check4Cancer to Advance AI-Powered Skin Cancer Detection

Check4Cancer is thrilled to announce the appointment of Dr Haider Raza to its Clinical Advisory Board, effective July 1, 2025. Dr Raza's vast experience and cutting-edge expertise in artificial intelligence (AI) and data-driven solutions will play a crucial role in furthering the development and global adoption of Check4Cancer’s AI model for skin cancer detection.

This strategic collaboration marks a significant milestone in Check4Cancer’s commitment to delivering innovative, reliable, and explainable AI solutions to improve patient care.

A Visionary Leader in AI and Health

Dr Haider Raza is a Senior Lecturer in the School of Computer Science & Electronic Engineering at the University of Essex. With an impressive background in machine learning, computational intelligence, and predictive analytics, Dr Raza is highly regarded for his innovative approach to solving clinical and public health challenges.

Notably, Dr Raza was a leading contributor to the Innovate UK Knowledge Transfer Partnerships program, a collaboration that was instrumental in the creation of Check4Cancer’s groundbreaking skin cancer AI detection model. His research portfolio further includes the development of AI-assisted decision-making systems for NHS Cancer Pathways in Essex, a project aimed at enhancing efficiency and precision in oncology care.

Beyond his technical achievements, Dr Raza is celebrated for his ability to bridge the gap between academic research and practical, real-world healthcare applications. His passion and expertise will strengthen Check4Cancer’s capacity to integrate AI technologies while maintaining a strong focus on patient safety and care outcomes.

Driving Innovation in Cancer Detection

Through this new role, Dr Raza will serve as a key advisor to both the Clinical Advisory Board and the data science team at Check4Cancer. His primary focus will include advancing the deployment of the AI-powered skin cancer detection model, offering strategic guidance on the adoption of new technologies, and ensuring that solutions adhere to strict standards for safety and reliability.

"As an advisor, Dr Raza’s contributions will help us make significant progress in early cancer detection globally," remarked a Check4Cancer spokesperson. "His expertise ensures that the emerging technologies we implement are both state-of-the-art and patient-centred."

A Commitment to Transforming Care

Dr Raza’s contribution to developing Check4Cancer’s AI model goes far beyond technical innovation. His involvement represents a personal commitment to improving healthcare access and outcomes for countless individuals. Reflecting on his appointment, Check4Cancer’s CEO and CMO, Professor Gordon Wishart says: "I am personally delighted that Dr Haider Raza has agreed to join the Check4Cancer team as an AI advisor. He was instrumental in developing our skin cancer AI model and will now help us deliver improved patient care by ensuring that our AI model is safe, reliable, and explainable."

Dr Raza says: “I am honoured to join the Clinical Advisory Board at Check4Cancer. It has been a privilege to collaborate on developing the AI-powered skin cancer detection model, an excellent example of translating academic research into real-world clinical impact. I look forward to contributing further to the safe and explainable adoption of AI in cancer detection and early diagnosis. Thank you to Professor Wishart and the Check4Cancer team for the trust and opportunity.”

A Step Forward in Patient-Centred AI

Check4Cancer’s mission has always been to push the boundaries of cancer detection by blending human expertise with advanced technologies. With Dr Raza on board, the organisation is poised to accelerate innovations in skin cancer prevention, diagnosis, and treatment both in the UK and worldwide.

This appointment underscores Check4Cancer’s determination to lead the way in implementing AI-driven healthcare solutions that are not only groundbreaking but also trustworthy and patient-focused.

Stay tuned for future updates as Dr Raza collaborates with Check4Cancer to redefine the possibilities of AI in skin cancer detection.